Romosozumab Completed Phase 4 Trials for Osteoporosis caused by Glucocorticoid Treatment Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04091243Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users